# Bloomlife

> Bloomlife is a San Francisco maternal health company that pairs FDA-cleared wearable sensors with a connected-care platform so high-risk pregnancies can be monitored from home. Born from a co-founder's own NICU experience, the company shifts prenatal care out of the clinic and into the living room - tracking fetal heart rate, blood pressure and glucose, then feeding the data to clinicians through risk-stratification tools meant to catch complications earlier.

- **Founded:** 2014
- **Headquarters:** San Francisco, United States
- **Founders:** Eric Dy (Co-Founder & CEO), Julien Penders (Co-Founder)
- **Team size:** approximately 37 employees
- **Products:** MFM-Pro, Connected Care Platform, Hypertension & Diabetes RPM Programs, Bloomlife Pregnancy Wearable (original)
- **Notable:** FDA clearance for the MFM-Pro wearable monitoring maternal and fetal heart rate, Secured insurance reimbursement across 18 payers, including Medicaid, Raised approximately $29M total across funding rounds

## Products & services

- **MFM-Pro** — FDA-cleared wearable device that monitors both maternal and fetal heart rates remotely, designed for home-based monitoring of high-risk pregnancies.
- **Connected Care Platform** — B2B2C platform that ships cellular-enabled monitoring kits to patients' homes and feeds blood pressure, glucose and fetal data back into clinical systems with risk-stratification and alerts.
- **Hypertension & Diabetes RPM Programs** — Remote patient monitoring programs for blood pressure and blood glucose during pregnancy, with planned expansion into maternal mental health and social determinants of health screening.
- **Bloomlife Pregnancy Wearable (original)** — Early direct-to-consumer medical-grade patch that let expecting mothers track uterine contractions; shipped to roughly 15,000 women and seeded an algorithm to identify labor onset.

## Achievements

- FDA clearance for the MFM-Pro wearable monitoring maternal and fetal heart rate
- Secured insurance reimbursement across 18 payers, including Medicaid
- Raised approximately $29M total across funding rounds
- Original wearable used by roughly 15,000 expecting mothers
- SOC 2 Type 2 security compliance
- Recognized by CES, NSF, AFWERX, MedTech Innovator and the J&J QuickFire challenge

## Latest updates

- **2024-09** — Closed a $12.2M Series A led by Kapor Capital and Noshaq to fund commercial expansion and a second FDA-cleared device.
- **2024-08** — MFM-Pro device received FDA clearance to monitor maternal and fetal heart rates remotely.
- **2024** — Platform expanded to include hypertension and diabetes management, with planned maternal mental health and SDOH screening.

## Links

- Website: https://www.bloom-life.com
- LinkedIn: http://www.linkedin.com/company/bloom-technologies
- Twitter/X: http://twitter.com/bloom_life
- Facebook: https://www.facebook.com/BloomLife

---

Profile page: https://yespress.io/bloomlife-inc
Published by YesPress — https://yespress.io
Last updated: 2026-06-29